Get started
Author

Chenicheri Kizhakkeveettil Keerthana

Observed names: C K Keerthana, C. K. Keerthana, C.K. Keerthana, Chenicheri K Keerthana, Chenicheri K. Keerthana
ORCID: 0000-0002-5910-6112
Observed ORCID: 0000-0002-5910-6112
OpenAlex ID: A5012928943
The role of AMPK in cancer metabolism and its impact on the immunomodulation of the tumor microenvironment
2023 · Chenicheri Kizhakkeveettil Keerthana, Tennyson Prakash Rayginia, et al. · Frontiers in Immunology · 210
PDF
Cancer Chemoprevention: A Strategic Approach Using Phytochemicals
2022 · Mohan Shankar G., Mundanattu Swetha, et al. · Frontiers in Pharmacology · 150
PDF
The emerging role of selenium metabolic pathways in cancer: New therapeutic targets for cancer
2021 · Kalishwaralal Kalimuthu, Chenicheri K. Keerthana, et al. · Journal of Cellular Biochemistry · 41
Unlocking nature’s pharmacy: an in-depth exploration of phytochemicals as potential sources of anti-cancer and anti-inflammatory molecules
2024 · Shifana C. Sadiq, Maria Pellissery Joy, et al. · Exploration of Drug Science · 21
Cucurbitacin B, Purified and Characterized From the Rhizome of Corallocarpus epigaeus Exhibits Anti-Melanoma Potential
2022 · Sreekumar Usha Devi Aiswarya, Gowda Vikas, et al. · Frontiers in Oncology · 19
Augmented Efficacy of Uttroside B over Sorafenib in a Murine Model of Human Hepatocellular Carcinoma
2022 · Mundanattu Swetha, Chenicheri K. Keerthana, et al. · Pharmaceuticals · 14
PDF
Phytochemicals as Potential Lead Molecules against Hepatocellular Carcinoma
2024 · Tennyson Prakash Rayginia, Chenicheri Kizhakkeveettil Keerthana, et al. · Current Medicinal Chemistry · 12
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma
2022 · Lekshmi R. Nath, Mundanattu Swetha, et al. · Frontiers in Oncology · 10
Enhanced extracellular vesicles mediated uttroside B (Utt-B) delivery to Hepatocellular carcinoma cell: Pharmacokinetics based on PBPK modelling
2024 · Kalimuthu Kalishwaralal, Abdul Azeez Nazeer, et al. · Biochemical and Biophysical Research Communications · 8
A Novel Combinatorial Regimen Using Sorafenib and Uttroside B, A US FDA-designated ‘Orphan Drug’, for the Treatment of Hepatocellular Carcinoma
2024 · Chenicheri Kizhakkeveettil Keerthana, Sreekumar U. Aiswarya, et al. · Anti-Cancer Agents in Medicinal Chemistry · 3
Kaempferide induces apoptosis in cervical cancer by attenuating the HPV oncoproteins, E6 and E7
2023 · Lekshmi R Nath, Vijai V Alex, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
2023 · Mohan Shankar Gopinatha Pillai, Sreekumar U. Aiswarya, et al. · iScience · 3
PDF
Selenium Metabolic Pathway in Ferroptotic Cell Death
2023 · Kalimuthu Kalishwaralal, Ajmani Abhishek, et al. · Springer eBooks · 3
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential
2022 · Sreekumar Usha Devi Aiswarya, Gowda Vikas, et al. · Frontiers in Oncology · 3
PDF
Putative role of uttronin (degalactotigonin) in cytotoxicity of uttroside B in HepG2 cells
2023 · Sanjay Suresh Varma, Sreekumar U. Aiswarya, et al. · Tetrahedron Letters · 2
Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma
2022 · Lekshmi R. Nath, Mundanattu Swetha, et al. · Frontiers in Oncology · 2
Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3
2026 · Chenicheri Kizhakkeveettil Keerthana, Tennyson P. Rayginia, et al. · Cell Death Discovery · 1
Orphan drug uttroside B impedes MASH progression and HCC development in experimental models
2025 · Tennyson P. Rayginia, Chenicheri K. Keerthana, et al. · JHEP Reports · 1
Bioactive Compounds in Cancer Therapy and Chemoprevention
2024 · Chenicheri Kizhakkeveettil Keerthana, Tennyson Prakash Rayginia, et al. · BENTHAM SCIENCE PUBLISHERS eBooks · 1
Evaluation of Uttroside B, a potent bioactive from Solanum nigrum Linn, as a candidate drug molecule against non-alcoholic fatty liver disease
2024 · Rayginia P Tennyson, Chenicheri K. Keerthana, et al. · Biomedicine · 1
PDF
Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma
2021 · Lekshmi R Nath, Mundanattu Swetha, et al. · SSRN Electronic Journal · 1
Evaluating the therapeutic efficacy of the US FDA-designated ‘Orphan drug’, uttroside B in impeding hepatocarcinogenesis via induction of immunogenic apoptosis, using a murine model of Aflatoxin B1-induced liver carcinogenesis
2025 · Mundanattu Swetha, Chenicheri Kizhakkeveettil Keerthana, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Uttroside B, a US-FDA-Designated Orphan Drug Against Hepatocellular Carcinoma (HCC), Impedes Non-alcoholic Steatohepatitis (NASH) and NASH -Induced HCC
2024 · Tennyson P Rayginia, Chenicheri K. Keerthana, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Role of Plant-Derived Extracellular Nanovesicles in Triggering Innate Immune Response Against Plant Pathogens
2024 · Vandana Sharma, Victor Samuel, et al. · CRC Press eBooks
Works count: 24
Citation count: 509
H-index: 8
I10-index: 8
Year
Topic
Type